Literature DB >> 8888004

The calcineurin inhibitor cyclosporin A-cyclophilin A complex reduces desensitization of GABAA-mediated responses in acutely dissociated rat hippocampal neurons.

M Martina1, J W Mozrzymas, H W Boddeke, E Cherubini.   

Abstract

The effects of the selective inhibitor of calcineurin, cyclosporin A-cyclophilin A (CC) complex on the desensitization kinetics of GABAA receptors was studied in acutely dissociated hippocampal neurons, using the patch clamp technique in the whole cell configuration. In control conditions, the decay of GABA-evoked current could be fitted by a biexponential function having time constants of 0.65 +/- 0.24 s and 3.75 +/- 2 s. The plateau to peak ratio was 0.087 +/- 0.034. Recovery from desensitization was obtained in more than 2 min. In cells dialyzed with the CC complex, the decay of the currents could be fitted with the sum of two exponentials having time constants similar to controls (0.81 +/- 0.47 s and 3.62 +/- 2.1 s), but the percentage of the fast component was smaller. The plateau to peak ratio was significantly larger than control (0.185 +/- 0.07). With CC complex, recovery from desensitization was completed in almost 30 s. The cyclosporin A derivative PSC 833, which does not inhibit calcineurin, did not affect desensitization kinetics. These results suggest that phosphatase 2B regulates desensitization of GABAA receptors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8888004

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  10 in total

1.  Trafficking of GABA(A) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus.

Authors:  David E Naylor; Hantao Liu; Claude G Wasterlain
Journal:  J Neurosci       Date:  2005-08-24       Impact factor: 6.167

Review 2.  Regulation of neuronal plasticity in the central nervous system by phosphorylation and dephosphorylation.

Authors:  M Tokuda; O Hatase
Journal:  Mol Neurobiol       Date:  1998       Impact factor: 5.590

3.  The absence of a major Ca2+ signaling pathway in GABAergic neurons of the hippocampus.

Authors:  A Sík; N Hájos; A Gulácsi; I Mody; T F Freund
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

4.  Shaping of IPSCs by endogenous calcineurin activity.

Authors:  M V Jones; G L Westbrook
Journal:  J Neurosci       Date:  1997-10-15       Impact factor: 6.167

5.  Enhanced desensitization followed by unusual resensitization in GABAA receptors in phospholipase C-related catalytically inactive protein-1/2 double-knockout mice.

Authors:  Hiroki Toyoda; Mitsuru Saito; Hajime Sato; Takuma Tanaka; Takeo Ogawa; Hirofumi Yatani; Tsutomu Kawano; Takashi Kanematsu; Masato Hirata; Youngnam Kang
Journal:  Pflugers Arch       Date:  2014-04-16       Impact factor: 3.657

6.  A role for calcineurin in Alzheimer's disease.

Authors:  Lindsay C Reese; Giulio Taglialatela
Journal:  Curr Neuropharmacol       Date:  2011-12       Impact factor: 7.363

Review 7.  Revisiting the Concept of Targeting NFAT to Control T Cell Immunity and Autoimmune Diseases.

Authors:  Jae-Ung Lee; Li-Kyung Kim; Je-Min Choi
Journal:  Front Immunol       Date:  2018-11-27       Impact factor: 7.561

8.  NFAT-Specific Inhibition by dNP2-VIVITAmeliorates Autoimmune Encephalomyelitisby Regulation of Th1 and Th17.

Authors:  Hong-Gyun Lee; Li-Kyung Kim; Je-Min Choi
Journal:  Mol Ther Methods Clin Dev       Date:  2019-10-23       Impact factor: 6.698

9.  Extrasynaptic and postsynaptic receptors in glycinergic and GABAergic neurotransmission: a division of labor?

Authors:  Emilie Muller; Hervé Le-Corronc; Pascal Legendre
Journal:  Front Mol Neurosci       Date:  2008-03-28       Impact factor: 5.639

Review 10.  Molecular and Regulatory Mechanisms of Desensitization and Resensitization of GABAA Receptors with a Special Reference to Propofol/Barbiturate.

Authors:  Youngnam Kang; Mitsuru Saito; Hiroki Toyoda
Journal:  Int J Mol Sci       Date:  2020-01-15       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.